Back to search

Switzerland· 42647012

Venoruton forte, Tabletten

A troxerutin, kombinationen, inkl. oxerutine product containing o-(2-hydroxyethyl)-rutosidea, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category D, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat D (Swissmedic)ATC C05CA54

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVenoruton forte, TablettenATCC05CA54REGISTER NO.42647012PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Troxerutin, kombinationen, inkl. oxerutine is registered in 4 of 19 countries.

Countries holding a registration under ATC C05CA54 (troxerutin, kombinationen, inkl. oxerutine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 4 of them publish a price we can compare per daily dose

Troxerutin, kombinationen, inkl. oxerutine · ATC C05CA54

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
O-(2-hydroxyethyl)-rutosidea
Manufacturer
Spirig HealthCare AG
Country
Switzerland (CH)
ATC code
C05CA54
ATC class
Troxerutin, Kombinationen, inkl. Oxerutine
Swissmedic category
D
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680426470125
    30 Stk
    CHF 16.65

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dcd8353e-0dd0-419a-9f7d-1fc47525998c
GET /v1/drugs/dcd8353e-0dd0-419a-9f7d-1fc47525998c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "o-(beta-hydroxyethyl)rutosidea (oxerutina) 500 mg",
  "valid_from": "1981-03-15",
  "limitations": null,
  "galenic_form": "Tabl 500 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1981-03-15",
  "self_retention_pct": 10
}

See everything about troxerutin, kombinationen, inkl. oxerutine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.